Moving from efficacy to effectiveness in cognitive behavioral therapy for psychosis: A randomized clinical practice trial

Journal of Consulting and Clinical Psychology

Volumn 80, Issue 4, 2012, Pages 674-686

  Lincoln, Tania M ^a   Ziegler, Michael ^a   Mehl, Stephanie ^a   Kesting, Marie Luise ^a   Lüllmann, Eva ^a   Westermann, Stefan ^a   Rief, Winfried ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

CBT; clinical practice; effectiveness; psychosis; schizophrenia

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COGNITIVE THERAPY; CONTROLLED STUDY; DELUSION; DEPRESSION; EFFECT SIZE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTPATIENT CARE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; THERAPY EFFECT; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; PSYCHOLOGY;

ADULT; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; WAITING LISTS;

EID: 84872236782     PISSN: 0022006X     EISSN: 19392117     Source Type: Journal    
DOI: 10.1037/a0028665     Document Type: Article

References (50)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Rating depression in schizophrenia. A comparison of a self-report and an observer report scale. Journal of Nervous and Mental Disease, 181, 561-565. doi:10.1097/00005053-199309000-00006
3. Andreasen, N. C., Carpenter, W. T., Jr., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005). Remission in schizophrenia: Proposed criteria and rationale for consensus. American Journal of Psychiatry, 162, 441-449. doi:10.1176/appi.ajp.162.3.441
4. Bechdolf, A., Knost, B., Kuntermann, C., Schiller, S., Klosterkötter, J., Hambrecht, M., & Pukrop, R. (2004). A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica, 110, 21-28. doi:10.1111/j.1600-0447.2004.00300.x
5. Beck, A. T., Rector, N. A., Stolar, N., & Grant, P. (2009). Schizophrenia: Cognitive theory, research, and therapy. New York, NY: Guilford Press.
6. Bernard, D., Lançon, C., Auquier, P., Reine, G., & Addington, D. (1998). Calgary Depression Scale for Schizophrenia: A study of the validity of a French-language version in a population of schizophrenic patients. Acta Psychiatrica Scandinavica, 97, 36-41. doi:10.1111/j.1600-0447.1998.tb09960.x
7. Chadwick, P., Birchwood, M., & Trower, P. (1996). Cognitive therapy for delusions, voices and paranoia. Chichester, England: Wiley.
8. Chambless, D. L., & Hollon, S. D. (1998). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7-18. doi:10.1037/0022-006X.66.1.7
9. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
10. Depp, C., & Lebowitz, B. D. (2007). Clinical trials: Bridging the gap between efficacy and effectiveness. International Review of Psychiatry, 19, 531-539. doi:10.1080/09540260701563320
11. Farhall, J., Freeman, N. C., Shawyer, F., & Trauer, T. (2009). An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosis. British Journal of Clinical Psychology, 48, 47-62. doi:10.1111/j.2044-8260.2009.tb00456.x
12. Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175-191. doi: 10.3758/BF03193146
13. Fenton, W. S. (2001). Comorbid conditions in schizophrenia. Current Opinion in Psychiatry, 14, 17-23. doi:10.1097/00001504-200101000-00004
14. Fowler, D., Garety, P., & Kuipers, E. (1995). Cognitive behaviour therapy for psychosis: Theory and practice. Chichester, England: Wiley.
15. Franke, G. (1995). Die Symptom-Checkliste von Derogatis-Deutsche Version [The Symptom Checklist by Derogatis-German Version]. Weinheim, Germany: Beltz.
16. Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004). Adherence to treatment with antipsychotic medication and health care costs among medical beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692-699. doi:10.1176/appi.ajp.161.4.692
17. Goodman, S. H., Sewell, D. R., Cooley, E. L., & Leavitt, N. (1993). Assessing levels of adaptive functioning: The Role Functioning Scale. Community Mental Health Journal, 29, 119-131. doi:10.1007/BF00756338
18. Grant, P. M., Huh, G. A., Perivoliotis, D., Stolar, N. M., & Beck, A. T. (2012). Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Archives of General Psychiatry, 69, 121-127. doi:10.1001/archgenpsychiatry.2011.129
19. Hautzinger, M., Bailer, M., Worall, H., & Keller, F. (1995). Beck-Depressions-Inventar [Beck Depression Inventory] (2nd ed.). Bern, Germany: Huber.
20. Jacobson, N. S., Follette, W. C., & Revenstorf, D. (1984). Psychotherapy outcome research: Methods for reporting variability and evaluating clinical significance. Behavior Therapy, 15, 336-352. doi:10.1016/S0005- 7894(84)80002-7
21. Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276. doi:10.1093/schbul/13.2.261
22. Kim, S.-W., Kim, S.-J., Yoon, B.-H., Kim, J.-M., Shin, I.-S., Hwang, M. Y., & Yoon, J.-S. (2006). Diagnostic validity of assessment scales for depression in patients with schizophrenia. Psychiatry Research, 144, 57-63. doi:10.1016/j.psychres.2005.10.002
23. Kingdon, D. G., & Turkington, D. (1994). Cognitive-behavioral therapy of schizophrenia. London, England: Guilford Press.
24. Kingdon, D. G., & Turkington, D. (2004). Cognitive therapy of schizophrenia. New York, NY: Guilford Press.
25. Klingberg, S., Wölwer, W., Engel, C., Wittorf, A., Herrlich, J., Meisner, C., Wiedemann, G. (2011). Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: Results of the randomized clinical TONES study. Schizophrenia Bulletin, 37, S98-S110. doi:10.1093/schbul/sbr073
26. Leucht, S., Barnes, T. R. E., Kissling, W., Engel, R. R., Correll, C., & Kane, J. M. (2003). Relapse prevention in schizophrenia with newgeneration antipsychotics: A systematic review and exploratory metaanalysis of randomized, controlled trials. American Journal of Psychiatry, 160, 1209-1222. doi:10.1176/appi.ajp.160.7.1209
27. Lincoln, T. (2006). Kognitive Verhaltenstherapie der Schizophrenie. Ein individuenzentrierter Ansatz zur Veränderung von Wahn, Halluzinationen und Negativsymptomatik [Cognitive behavior therapy for schizophrenia: An individual-centered approach to changing delusions, hallucinations and negative symptoms]. Göttingen, Germany: Hogrefe.
28. Lincoln, T. M., Keller, E., & Rief, W. (2009). Die Erfassung von Wahn und Halluzinationen in der Normalbevölkerung. Deutsche Adaptationen des Peters et al. Delusions Inventory (PDI) und der Launay Slade Hallucination Scale (LSHS-R) [The assessment of delusions and hallucinations in the normal population: German adaptations of the Peters et al. Delusions Inventory (PDI) and the Launay Slade Hallucination Scale (LSHS-R)]. Diagnostica, 55, 29-40. doi:10.1026/0012-1924.55.1.29
29. Lincoln, T. M., Mehl, S., Kesting, M.-L., & Rief, W. (2011). Negative symptoms and social cognition: Identifying targets for psychological interventions. Schizophrenia Bulletin, 37, S23-S32. doi:10.1093/schbul/sbr066
30. Lincoln, T. M., Suttner, C., & Nestoriuc, Y. (2008). Wirksamkeit kognitiver Interventionen für Schizophrenie. Eine Meta-Analyse [Effectiveness of cognitive interventions for schizophrenia. A meta-analysis]. Psychologische Rundschau, 59, 217-232. doi:10.1026/0033-3042.59.4.217
31. Lipsey, M. W., & Wilson, D. B. (2001). Practical meta-analyses. London, England: Sage.
32. Morrison, A. P., Hutton, P., Wardle; M., Spencer, H., Barratt, S., Brabban, A., Turkington, D. (2012). Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: An exploratory trial. Psychological Medicine, 42, 1049-1056. doi: 10.1017/S0033291711001899.
33. Morrison, A. P., Renton, J. C., Williams, S., Dunn, H., Knight, A., Kreutz, M., . . . Dunn, G. (2004). Delivering cognitive therapy to people with psychosis in a community health setting: An effectiveness study. Acta Psychiatrica Scandinavica, 110, 36-44. doi:10.1111/j.1600-0447.2004.00299.x
34. Müller, M. J., Brening, H., Gensch, C., Klinga, J., Kienzle, B., & Müller, K.-M. (2005). The Calgary Depression Rating Scale for Schizophrenia in a healthy control group: Psychometric properties and reference values. Journal of Affective Disorders, 88, 69-74. doi:10.1016/j.jad.2005.04.005
35. Müller, M. J., & Lincoln, T. M. (2012). How do "normal" subjects fare on the PANSS? A cross-sectional assessment of psychotic symptoms in a healthy sample. Manuscript submitted for publication.
36. Müller, M. J., Marx-Dannigkeit, P., Schlösser, R., Wetzel, H., Addington, D., & Benkert, O. (1999). The Calgary Depression Rating Scale for Schizophrenia: Development and interrater reliability of a German version (CDSS-G). Journal of Psychiatric Research, 33, 433-443. doi: 10.1016/S0022-3956(99)00018-7
37. Peters, E. R., Joseph, S. A., & Garety, P. A. (1999). Measurement of delusional ideation in the normal population: Introducing the PDI (Peters et al. Delusions Inventory). Schizophrenia Bulletin, 25, 553-576. doi: 10.1093/oxfordjournals.schbul.a033401
38. Peters, E., Landau, S., McCrone, P., Cooke, M., Fisher, P., Steel, C., . . . Kuipers, E. (2010). A randomised controlled trial of cognitive behavior therapy for psychosis in a routine clinical service. Acta Psychiatrica Scandinavica, 122, 302-318. doi:10.1111/j.1600-0447.2010.01572.x
39. Rector, N. A., Seeman, M. V., & Segal, Z. V. (2003). Cognitive therapy for schizophrenia: A preliminary randomized trial. Schizophrenia Research, 63, 1-11. doi:10.1016/S0920-9964(02)00308-0
40. Rollinson, R., Haig, C., Warner, R., Garety, P., Kuipers, E., Freeman, D., . . . Fowler, D. (2007). The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Psychiatric Services, 58, 1297-1302. doi:10.1176/appi.ps.58.10.1297
41. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. British Medical Journal, 340, c332. doi:10.1136/bmj.c1332
42. Tungström, S., Söderberg, P., & Armelius, B.-Å. (2005). Relationship between the Global Assessment of Functioning and other DSM axes in routine clinical work. Psychiatric Services, 56, 439-443. doi:10.1176/appi.ps.56.4.439
43. Valmaggia, L. R., Van der Gaag, M., Tarrier, N., Pijnenborg, M., & Sloof, C. J. (2005). Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical medication: Randomised controlled trial. British Journal of Psychiatry, 186, 324-330. doi:10.1192/bjp.186.4.324
44. Wechsler, D. (1981). Wechsler Adult Intelligence Test-Revised. New York, NY: Psychological Corporation.
45. Weiss, A. P., Guidi, J., & Fava, M. (2009). Closing the efficacy-effectiveness gap: Translating both the what and the how from randomized controlled trials to clinical practice. Journal of Clinical Psychiatry, 70, 446-449. doi:10.4088/JCP.08com04901
46. Weisz, J. R., Donenberg, G. R., Han, S. S., & Weiss, B. (1995). Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. Journal of Consulting and Clinical Psychology, 63, 688-701. doi:10.1037/0022-006X.63.5.688
47. Wittchen, H. U., Zaudig, M., & Fydrich, T. (1997). Strukturiertes Klinisches Interview für DSM-IV [Structured Clinical Interview for DSM-IV]. Göttingen, Germany: Hogrefe.
48. Wittorf, A., Jakobi, U., Bechdolf, A., Müller, B., Sartory, G., Wagner, M., . . . Klingberg, S. (2009). The influence of baseline symptoms and insight on the therapeutic alliance early in the treatment of schizophrenia. European Psychiatry, 24, 259-267. doi:10.1016/j.eurpsy .2008.12.015
49. Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2008). Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34, 523-537. doi:10.1093/schbul/ sbm114
50. Xiao, W., Liu, H., Zhang, H., Liu, Q., Fu, P., Chen, J., . . . Shu, L. (2009). Reliability and validity of the Chinese version of the Calgary Depression Scale for Schizophrenia. Australian and New Zealand Journal of Psychiatry, 43, 548-553. doi:10.1080/00048670902873672